Shenzhen New Industries Biomedical Engineering Co Ltd banner

Wall St Price Targets

Price Forecast
Based on 10 analysts

+11% Upside
from ¥62.76 today

Shenzhen New Industries Biomedical Engineering Co Ltd (300832)’s 12-month stock price forecast through November 2027 has a consensus target of ¥69.36, implying 11% upside. The forecast is based on price targets from 10 Wall Street analysts.

Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for Shenzhen New Industries Biomedical Engineering Co Ltd yet.

Shenzhen New Industries Biomedical Engineering Co Ltd Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Shenzhen New Industries Biomedical Engineering Co Ltd's stock price target?
Price Target
69.36 CNY

According to Wall Street analysts, the average 1-year price target for Shenzhen New Industries Biomedical Engineering Co Ltd is 69.36 CNY with a low forecast of 62.62 CNY and a high forecast of 91.56 CNY.

What is the Revenue forecast for Shenzhen New Industries Biomedical Engineering Co Ltd?
Projected CAGR
14%

Over the last 12 years, the compound annual growth rate for Revenue has been 23%. The projected CAGR for the next 3 years is 14%.

What is the Gross Profit forecast for Shenzhen New Industries Biomedical Engineering Co Ltd?
Projected CAGR
15%

Over the last 12 years, the compound annual growth rate for Gross Profit has been 23%. The projected CAGR for the next 3 years is 15%.

What is the Operating Income forecast for Shenzhen New Industries Biomedical Engineering Co Ltd?
Projected CAGR
18%

Over the last 12 years, the compound annual growth rate for Operating Income has been 22%. The projected CAGR for the next 3 years is 18%.

What is the Pre-Tax Income forecast for Shenzhen New Industries Biomedical Engineering Co Ltd?
Projected CAGR
16%

Over the last 12 years, the compound annual growth rate for Pre-Tax Income has been 22%. The projected CAGR for the next 3 years is 16%.

What is the Net Income forecast for Shenzhen New Industries Biomedical Engineering Co Ltd?
Projected CAGR
16%

Over the last 12 years, the compound annual growth rate for Net Income has been 22%. The projected CAGR for the next 3 years is 16%.

Back to Top